Long-lasting neutralizing antibodies and T cell response after the third dose of mRNA anti-SARS-CoV-2 vaccine in multiple sclerosis
多发性硬化症患者接种第三剂 mRNA 抗 SARS-CoV-2 疫苗后持久的中和抗体和 T 细胞反应
期刊:Frontiers in Immunology
影响因子:5.7
doi:10.3389/fimmu.2023.1205879
Alessandro Maglione, Rachele Francese, Irene Arduino, Rachele Rosso, Manuela Matta, Simona Rolla, David Lembo, Marinella Clerico
